| 注册
首页|期刊导航|中国医学创新|达格列净联合甘精胰岛素对早期糖尿病肾病患者肾功能指标及血糖控制效果的影响

达格列净联合甘精胰岛素对早期糖尿病肾病患者肾功能指标及血糖控制效果的影响

华华 樊华 邹思璐 余红英

中国医学创新2024,Vol.21Issue(19):111-114,4.
中国医学创新2024,Vol.21Issue(19):111-114,4.DOI:10.3969/j.issn.1674-4985.2024.19.025

达格列净联合甘精胰岛素对早期糖尿病肾病患者肾功能指标及血糖控制效果的影响

Effects of Dapagliflozin Combined with Insulin Glargine on Renal Function Indexes and Blood Glucose Control in Patients with Early Diabetic Nephropathy

华华 1樊华 1邹思璐 1余红英1

作者信息

  • 1. 景德镇市第二人民医院药剂科 江西 景德镇 333000
  • 折叠

摘要

Abstract

Objective:To investigate the effect of Dapagliflozin combined with Insulin Glargine in early diabetic nephropathy patients.Method:A total of 108 patients with early diabetic nephropathy admitted to Jingdezhen Second People's Hospital from December 2021 to December 2023 were divided into two groups according to random number table method,with 54 patients in each group.The control group was treated with Insulin Glargine,and the observation group was treated with Dapagliflozin on the basis of control group.The clinical efficacy,renal function index,blood glucose index and the occurrence of adverse reactions were observed and compared between the two groups.Result:The total effective rate of the observation group was 90.74%,which was higher than 72.22% of the control group,the difference was statistically significant(P<0.05).After treatment,the levels of blood urea nitrogen(BUN),blood creatinine(Scr),urinary microalbumin(mALB)and urinary albumin to creatinine ratio(ACR)in both groups were lower than those before treatment,the estimated glomerular filtration rate(eGFR)was significantly higher than that before treatment,and BUN,Scr,mALB and ACR in observation group were lower than those in control group,and eGFR was higher than that in control group,the differences were statistically significant(P<0.05).After treatment,the levels of glycated hemoglobin(HbA1c),fasting blood glucose(FBG),daily mean amplitude of glycemic excursions(MAGE)and 2 h postprandial blood glucose(2 h PG)in two groups were lower than those before treatment,and those in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(字2=1.582,P=0.207).Conclusion:Dapagliflozin combined with Insulin Glargine has a definite effect in the treatment of elderly diabetic nephropathy patients,which can effectively regulate blood glucose level and facilitate the recovery of renal function with good safety.

关键词

糖尿病肾病/早期/达格列净/甘精胰岛素/肾功能/血糖

Key words

Diabetic nephropathy/Early/Dapagliflozin/Insulin Glargine/Renal function/Blood glucose

引用本文复制引用

华华,樊华,邹思璐,余红英..达格列净联合甘精胰岛素对早期糖尿病肾病患者肾功能指标及血糖控制效果的影响[J].中国医学创新,2024,21(19):111-114,4.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文